|
1.
|
Bray F, McCarron P and Parkin DM: The
changing global patterns of female breast cancer incidence and
mortality. Breast Cancer Res. 6:229–239. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Stewart BW and Coates AS: Cancer
prevention: a global perspective. J Clin Oncol. 23:392–403. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Smith MD and McGhan WF: Financial facts
about treating breast cancer. Bus Health. 14:67–68.
70:1996.PubMed/NCBI
|
|
4.
|
Spitler LE: Clinical uses of transfer
factor. Calif Med. 118:471973.PubMed/NCBI
|
|
5.
|
Mackall CL, Fleisher TA, Brown MR, Magrath
IT, Shad AT, Horowitz ME, Wexler LH, Adde MA, McClure LL and Gress
RE: Lymphocyte depletion during treatment with intensive
chemotherapy for cancer. Blood. 84:2221–2228. 1994.PubMed/NCBI
|
|
6.
|
Van der Most RG, Currie AJ, Robinson BW
and Lake RA: Decoding dangerous death: how cytotoxic chemotherapy
invokes inflammation, immunity or nothing at all. Cell Death
Differ. 15:13–20. 2008.PubMed/NCBI
|
|
7.
|
Piper BF, Borneman T, Sun VC, Koczywas M,
Uman G, Ferrell B and James RL: Cancer-related fatigue: role of
oncology nurses in translating National Comprehensive Cancer
Network Assessment Guidelines into practice. Clin J Oncol Nurs.
12:37–47. 2008. View Article : Google Scholar
|
|
8.
|
Berger AM: Patterns of fatigue and
activity and rest during adjuvant breast cancer chemotherapy. Oncol
Nurs Forum. 25:51–62. 1998.PubMed/NCBI
|
|
9.
|
Goodman MN: Tumor necrosis factor induces
skeletal muscle protein breakdown in rats. Am J Physiol.
260:E727–E730. 1991.PubMed/NCBI
|
|
10.
|
Karnofsky DA, Abelmann WH and Craver LF:
The use of the nitrogen mustards in palliative treatment of
carcinoma. Cancer. 1:634–656. 1948. View Article : Google Scholar
|
|
11.
|
Priestman TJ and Baum M: Evaluation of
quality of life in patients receiving treatment for advanced breast
cancer. Lancet. 1:899–900. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Kasper CE: Sarcolemmal disruption in
reloaded atrophic skeletal muscle. J Appl Physiol. 79:607–614.
1995.PubMed/NCBI
|
|
13.
|
Kasper CE: Recovery of plantaris muscle
from impaired physical mobility. Biol Res Nurs. 1:4–11. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Kasper CE and Sarna LP: Influence of
adjuvant chemotherapy on skeletal muscle and fatigue in women with
breast cancer. Biol Res Nurs. 2:133–139. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
St Pierre BA, Kasper CE and Lindsey AM:
Fatigue mechanisms in patients with cancer: effects of tumor
necrosis factor and exercise on skeletal muscle. Oncol Nurs Forum.
19:419–425. 1992.PubMed/NCBI
|
|
16.
|
Lawrence HS and Borkowsky W: Transfer
factor – current status and future prospects. Biotherapy. 9:1–5.
1996.
|
|
17.
|
Kirkpatrick CH: Transfer of cellular
immunity with transfer factor. J Allergy Clin Immunol. 63:71–73.
1979. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Vacek A, Hofer M, Schneiderova H and
Svoboda J: Ultrafiltered pig leukocyte extract (UPLE, IMUNOR)
potentiates hematopoiesis-stimulating effects of G-CSF in vitro and
improves the outcome of treatment of hematopoietic radiation damage
in mice with G-CSF. Immunopharmacol Immunotoxicol. 27:647–659.
2005. View Article : Google Scholar
|
|
19.
|
Pizzo PA, Henderson ES and Leventhal BG:
Acute myelogenous leukemia in children: a preliminary report of
combination chemotherapy. J Pediatr. 88:125–130. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Franco-Molina MA, Mendoza-Gamboa E,
Castillo-Leon L, Tamez-Guerra RS and Rodriguez-Padilla C: Bovine
dialyzable leukocyte extract protects against LPS-induced, murine
endotoxic shock. Int Immunopharmacol. 4:1577–1586. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Atzpodien J, Kuchler T, Wandert T and
Reitz M: Rapid deterioration in quality of life during
interleukin-2- and alpha-interferon-based home therapy of renal
cell carcinoma is associated with a good outcome. Br J Cancer.
89:50–54. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Ojeda MO, van't Veer C, Fernandez Ortega
CB, Arana Rosainz MJ and Buurman WA: Dialyzable leukocyte extract
differentially regulates the production of TNFalpha, IL-6 and IL-8
in bacterial component-activated leukocytes and endothelial cells.
Inflamm Res. 54:74–81. 2005. View Article : Google Scholar
|
|
23.
|
Kirkpatrick CH, Rozzo SJ, Mascali JJ and
Merryman CF: Murine transfer factor. II. Transfer of delayed
hypersensitivity to synthetic antigens. J Immunol. 134:1723–1727.
1985.PubMed/NCBI
|
|
24.
|
Kirkpatrick CH: Therapeutic potential of
transfer factor. N Engl J Med. 303:390–391. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Kirkpatrick CH: Transfer of delayed
cutaneous hypersensitivity with transfer factor. Cell Immunol.
41:62–71. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Franco-Molina MA, Mendoza-Gamboa E,
Miranda-Hernandez D, Zapata-Benavides P, Castillo-Leon L,
Isaza-Brando C, Tamez-Guerra RS and Rodriguez-Padilla C: In vitro
effects of bovine dialyzable leukocyte extract (BDLE) in cancer
cells. Cytotherapy. 8:408–414. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Mendoza-Gamboa E, Franco-Molina MA,
Zapata-Benavides P, Castillo-Tello P, Vera-Garcia ME, Tamez-Guerra
RS and Rodriguez-Padilla C: Bovine dialyzable leukocyte extract
modulates AP-1 DNA-binding activity and nuclear transcription
factor expression in MCF-7 breast cancer cells. Cytotherapy.
10:212–219. 2008. View Article : Google Scholar
|
|
28.
|
Oettgen HF, Old LJ, Farrow JH, Valentine
FT, Lawrence HS and Thomas L: Effects of dialyzable transfer factor
in patients with breast cancer. Proc Natl Acad Sci USA.
71:2319–2323. 1974. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Pineda B, Estrada-Parra S, Pedraza-Medina
B, Rodriguez-Ropon A, Perez R and Arrieta O: Interstitial transfer
factor as adjuvant immunotherapy for experimental glioma. J Exp
Clin Cancer Res. 24:575–583. 2005.PubMed/NCBI
|
|
30.
|
Meier CR and LoBuglio AF: Transfer factor:
a potential agent for immunotherapy of cancer. World J Surg.
1:617–623. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Goldenberg GJ and Brandes LJ: In vivo and
in vitro studies of immunotherapy of nasopharyngeal carcinoma with
transfer factor. Cancer Res. 36:720–723. 1976.PubMed/NCBI
|
|
32.
|
Moss RW: Cancer and complementary and
alternative medicine in Italy: personal observations and historical
considerations. Integr Cancer Ther. 3:173–188. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Pizza G, De VC, Cuzzocrea D, Menniti D,
Aiello E, Maver P, Corrado G, Romagnoli P, Dragoni E and LoConte G:
A preliminary report on the use of transfer factor for treating
stage D3 hormone-unresponsive metastatic prostate cancer.
Biotherapy. 9:123–132. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Rodriguez-Flores A, Castillo-Juarez P,
Vazquez D, Gonzalez-Guzman R, Rico-Martinez G and Estrada-Parra S:
Immunological evaluation of patients with osteosarcoma received
adjuvant treatment with specific transfer factor. J Immunol.
182:632009.
|
|
35.
|
Dudley ME, Wunderlich JR, Yang JC, Sherry
RM, Topalian SL, Restifo NP, Royal RE, Kammula U, White DE and
Mavroukakis SA: Adoptive cell transfer therapy following
non-myeloablative but lymphodepleting chemotherapy for the
treatment of patients with refractory metastatic melanoma. J Clin
Oncol. 23:2346–2357. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Franco-Molina MA, Mendoza-Gamboa E,
Zapata-Benavides P, Vera-Garcia ME, Castillo-Tello P, Garcia dlF,
Mendoza RD, Garza RG, Tamez-Guerra RS and Rodriguez-Padilla C:
IMMUNEPOTENT CRP (bovine dialyzable leukocyte extract) adjuvant
immunotherapy: a phase I study in non-small cell lung cancer
patients. Cytotherapy. 10:490–496. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Fujisawa T: Transfer factor immunotherapy
as an adjunct to surgery in lung cancer. Nihon Kyobu Shikkan Gakkai
Zasshi. 23:68–73. 1985.PubMed/NCBI
|
|
38.
|
Krown SE, Pinsky CM, Hirshaut Y, Hansen JA
and Oettgen HF: Effects of transfer factor in patients with
advanced cancer. Isr J Med Sci. 14:1026–1038. 1978.PubMed/NCBI
|
|
39.
|
Vacek A, Hofer M, Hola J, Weiterova L,
Streitova D and Svoboda J: The role of G-CSF and IL-6 in the
granulopoiesis-stimulating activity of murine blood serum induced
by perorally administered ultrafiltered pig leukocyte extract,
IMUNOR. Int Immunopharmacol. 7:656–661. 2007. View Article : Google Scholar
|
